Cargando…

Rescue therapy with an albuvirtide-based antiretroviral regimen in an HIV-infected child with multidrug resistance and multiple opportunistic infections: a case report

BACKGROUND: Managing multidrug-resistant (MDR) HIV infections in children is particularly challenging due to the lack of experience with new drugs in the pediatric setting. Second-line albuvirtide (ABT) with an optimized antiretroviral background therapy was approved for adults and adolescents after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Wei, Song, Xiao-yun, Cao, Jing, Liu, Chun, Zheng, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463494/ https://www.ncbi.nlm.nih.gov/pubmed/37641133 http://dx.doi.org/10.1186/s12981-023-00560-w

Ejemplares similares

Tolerability and Adherence of Antiretroviral Regimens Containing Long-Acting Fusion Inhibitor Albuvirtide for HIV Post-Exposure Prophylaxis: A Cohort Study in China
por: Nie, Jingmin, et al.
Publicado: (2021)

Tolerability and effectiveness of albuvirtide combined with dolutegravir for hospitalized people living with HIV/AIDS
por: Liu, Huanxia, et al.
Publicado: (2023)

Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects
por: Fonsah, Julius Y., et al.
Publicado: (2017)

Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia
por: Mitiku, Habtamu, et al.
Publicado: (2015)

Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patients
por: Zhang, Hongwei, et al.
Publicado: (2016)

Comparing albuvirtide plus ritonavir-boosted lopinavir regimen to two nucleotide reverse transcriptase inhibitors plus ritonavir-boosted lopinavir in HIV-infected individuals who failed initial treatment: a retrospective comparative cohort study
por: Chen, Liyu, et al.
Publicado: (2022)

Effectiveness of Multidrug Antiretroviral Regimens to Prevent Mother-to-Child Transmission of HIV-1 in Routine Public Health Services in Cameroon
por: Tchendjou, Patrice, et al.
Publicado: (2010)

Biophysical Property and Broad Anti-HIV Activity of Albuvirtide, a 3-Maleimimidopropionic Acid-Modified Peptide Fusion Inhibitor
por: Chong, Huihui, et al.
Publicado: (2012)

Forecast analysis of any opportunistic infection among HIV positive individuals on antiretroviral therapy in Uganda
por: Rubaihayo, John, et al.
Publicado: (2016)

The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic Infections
Publicado: (2016)

Enteric Opportunistic Infection and the Impact of Antiretroviral Therapy among HIV/AIDS Patients from Tehran, Iran
por: MASOUMI-ASL, Hossein, et al.
Publicado: (2019)

The spectrum of opportunistic infections and malignancies among women on antiretroviral therapy in Ethiopia
por: Getaneh, Yimam, et al.
Publicado: (2023)

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
por: Bîstrițchi, Ina, et al.
Publicado: (2013)

Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens
por: Pinto-Cardoso, Sandra, et al.
Publicado: (2017)

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults
por: DeJesus, Edwin, et al.
Publicado: (2019)

Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS
por: Yen, Yung-Feng, et al.
Publicado: (2019)

Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
por: Chiampas, Thomas D., et al.
Publicado: (2019)

Brain opportunistic infections and tumors in people living with HIV — still a challenge in efficient antiretroviral therapy era
por: Oprea, Cristiana, et al.
Publicado: (2023)

Prevalence and determinants of opportunistic infections among HIV-infected adults receiving antiretroviral therapy in Ethiopia: A systematic review and meta-analysis
por: Woldegeorgis, Beshada Zerfu, et al.
Publicado: (2023)

Cushing’s syndrome complicated by multiple opportunistic infections
por: Bakker, R. C., et al.
Publicado: (2014)

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
por: Ciaffi, Laura, et al.
Publicado: (2015)

Opportunistic Infections
por: Lawler, Melissa, et al.
Publicado: (2020)

Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi
por: Tweya, Hannock, et al.
Publicado: (2014)

Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study
por: Su, Bin, et al.
Publicado: (2020)

Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014
por: Tanuma, Junko, et al.
Publicado: (2016)

The magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in southern zone Tigray, Ethiopia: a cross-sectional study
por: Weldearegawi, Teklay Zeru, et al.
Publicado: (2020)

Patients’ Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIV
por: Engelhard, Esther A. N., et al.
Publicado: (2016)

Evaluation of the occurrence and type of antiretroviral and opportunistic infection medication errors within the inpatient setting
por: Chiampas, Thomas D., et al.
Publicado: (2015)

Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda
por: Binagwaho, Agnes, et al.
Publicado: (2013)

Opportunistic infections in persons with HIV or other immunocompromising conditions.
por: Kaplan, J E, et al.
Publicado: (2001)

Opportunistic Infections in HIV Seropositive Individuals: CME Lecture
por: Gazzard, B G
Publicado: (1995)

Opportunistic digestive parasitic infections in adults infected with HIV: epidemiological expression
por: Badaoui, L, et al.
Publicado: (2014)

Treatment-Emergent Mutations and Resistance in HIV-Infected Children Treated with Fosamprenavir-Containing Antiretroviral Regimens
por: Ross, Lisa L, et al.
Publicado: (2015)

Comparison of Two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV−) Infected Pregnant Women
por: Tate, Danielle, et al.
Publicado: (2017)

557. Evaluation of Clinical Response of a Two Tablet Once Daily Antiretroviral Regimen in Antiretroviral Experienced HIV-Infected Patients
por: Maki, Gina, et al.
Publicado: (2018)

Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
por: Low, Andrea, et al.
Publicado: (2016)

Recent trends in the spectrum of opportunistic infections in human immunodeficiency virus infected individuals on antiretroviral therapy in South India
por: Shahapur, Praveen R., et al.
Publicado: (2014)

Clinical Course of Opportunistic Infections—Toxoplasmosis and Cytomegalovirus Infection in HIV-Infected Patients in Slovakia
por: Šimeková, Katarína, et al.
Publicado: (2019)

Opportunist Lung Infections
por: Lambert, H. P.
Publicado: (1979)

Histoplasma stomatitis unveiled: Not all opportunistic infections get better after initiation of antiretroviral therapy
por: Bansal, Saurabh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_elglh4bf7h6j9shnqve5bchohp